Humana ABLTS:0RF7 +3.44%67 PB Ratio is 0.72 as of Jun. 26, 2026, which is 40% below its 10-year median of 1.20. GuruFocus rates LTS:0RF7 with a GF Score™ of 67/100 and a GF Value™ of kr36.46 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 611 Healthcare Providers & Services companies, Humana AB ranks better than 86.58% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-26), Humana AB's share price is kr48.125. Humana AB's Book Value per Share for the quarter that ended in Mar. 2026 was kr66.46. Hence, Humana AB's PB Ratio of today is 0.72.
The historical rank and industry rank for Humana AB's PB Ratio or its related term are showing as below:
LTS:0RF7'
s PB Ratio Range Over the Past 10 Years
Min: 0.23 Med: 1.2 Max: 2.87
Current: 0.71
During the past 13 years, Humana AB's highest PB Ratio was 2.87. The lowest was 0.23. And the median was 1.20.
LTS:0RF7's PB Ratio is ranked better than 86.58% of 611
companies
in the Healthcare Providers & Services industry
Industry Median: 1.98
vs LTS:0RF7: 0.71
During the past 12 months, Humana AB's average Book Value Per Share Growth Rate was 6.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 4.00% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Humana AB was 20.40% per year. The lowest was 4.00% per year. And the median was 9.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Humana AB PB Ratio Related Terms
Humana AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Humana AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Humana AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Humana AB PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Humana AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Humana AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Humana AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Humana AB (LTS:0RF7) has a PB Ratio of 0.72 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Humana AB and its competitors. This is 40% below median its historical median of 1.20. Over the past decade, Humana AB's PB Ratio has ranged from 0.23 to 2.87. According to the industry distribution chart, Humana AB ranks #82 out of 611 companies in the Healthcare Providers & Services industry, placing it in the top 13.4%.
Is Humana AB's PB Ratio too high?
Humana AB's current PB Ratio of 0.72 is 40% below median its 10-year median of 1.20. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 2.87. The Healthcare Providers & Services industry median PB Ratio is 1.98. Humana AB's value of 0.72 is 63.6% below this industry median. Based on the distribution chart, Humana AB ranks #82 out of 611 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Humana AB has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Humana AB's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Humana AB ranks #82 out of 611 companies for PB Ratio. This places Humana AB in the top 13% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.98. Humana AB's value of 0.72 is 63.6% below this benchmark. Historically, Humana AB's own PB Ratio has ranged from 0.23 to 2.87 over the past decade. While the company's 10-year median is 1.20 vs. the industry median of 1.98, Humana AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.98, based on 611 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Humana AB's current PB Ratio of 0.72 is 63.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Humana AB and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Humana AB's current PB Ratio is 0.72, which is 40% below median its own 10-year median of 1.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Humana AB stock overvalued right now?
Based on GuruFocus' analysis, Humana AB (LTS:0RF7) is currently considered Significantly Overvalued. The stock's GF Value™ is kr36.46, compared to a current price of kr48.13 — trading 32% above its estimated fair value. The current PB Ratio is 0.72, which is 40% below median its 10-year median of 1.20 and 63.6% below the Healthcare Providers & Services industry median of 1.98. Humana AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Humana AB (LTS:0RF7), the current PB Ratio is 0.72 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Humana AB (LTS:0RF7) Overvalued in 2026?
Based on GuruFocus' analysis, Humana AB stock appears to be overvalued.
The current stock price of kr48.13 is trading 32% above its estimated GF Value™ of kr36.46.
GuruFocus considers Humana AB to be Significantly Overvalued.
Key valuation signals for LTS:0RF7:
PB Ratio: 0.72 (40% below median its 10-year median of 1.20)
GF Value™: kr36.46 vs. price of kr48.13 (32% above fair value)
Industry Position: 63.6% below the Healthcare Providers & Services median (#82 of 611)
No single metric tells the full story. See the LTS:0RF7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Humana AB is a provider of private care services in the Nordic region. The company offers services including individual and family care, personal assistance, elderly care and housing with special services. Geographically, the company operates in Sweden, Norway, Finland, Denmark, and others. It derives maximum revenue from Sweden.
67GF Score
Get the complete analysis for LTS:0RF7
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0RF7 has been successfully added to your 
